https://doi.org/
Poster
NOT PEER REVIEWED
Download
metrics
VIEWS
592
 
downloads
73
CITE
How to cite this poster:
Gille A, Easton R, Wright SD and Shear CL CSL112, a novel formulation of human apolipoprotein A-I, dramatically increases cholesterol efflux capacity in healthy subjects: a placebo-controlled, double-blinded, randomized, single ascending dose study. F1000Posters 2012, 3:1589 (poster)

CSL112, a novel formulation of human apolipoprotein A-I, dramatically increases cholesterol efflux capacity in healthy subjects: a placebo-controlled, double-blinded, randomized, single ascending dose study

Andreas Gille1, Rachael Easton, Samuel D Wright, Charles L Shear
Published 18 Dec 2012
Author Affiliations
  • Metrics
  • 592 Views
  • 73 Downloads
 
Part of the collection
Browse by related subjects
Published 18 Dec 2012

CSL112, a novel formulation of human apolipoprotein A-I, dramatically increases cholesterol efflux capacity in healthy subjects: a placebo-controlled, double-blinded, randomized, single ascending dose study

[version 1; not peer reviewed]

Andreas Gille1, Rachael Easton, Samuel D Wright, Charles L Shear
Author Affiliations
1 CSL Limited, Australia
Presented at
American Heart Association Scientific Session 2012
Abstract
Competing Interests

CSL Limited provided the funding for the clinical trial. All the authors are paid employees of CSL Limited or CSL Behring.

Comments
0 Comments
 
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.